Aju IB Invesment Corporation — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
Carisma Therapeuticscarismatx.comDec 2020
CAR-Macrophage cellular therapeutics with initial oncology focus (NASDAQ: CARM).
BiotechPhiladelphia, US
Steven Kelly(Executive Officer, Director)
BoardMargarita Chavez(Director)Eran Nadav(Director)Althea Stillman(Director)Jacob Gunterberg(Director)Regina Hodits(Director)
Co-investorsAnzu PartnersGrazia Equity GmbHHealthCapMRL Ventures FundSolasta VenturesAgent Capital+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.